Logo Logo
Switch Language to German

Hering, Thomas; Batra, Anil; Muehlig, Stephan; Nowak, Dennis ORCID logoORCID: https://orcid.org/0000-0001-7871-8686; Ruther, Tobias and Schwarzkopf, Larissa (2021): Das Einsparpotenzial der Behandlungskosten bei COPD durch Rauchstopp – Modellierung für DMP COPD in Deutschland. Wissenschaftlicher Aktionskreis Tabakentwöhnung (WAT) e. V. In: Pneumologie, Vol. 75, No. 8: pp. 577-582

Full text not available from 'Open Access LMU'.


Based on real-life data for the stage distribution of COPD patients (GOLD) and the actual stage-related treatment costs in a large nationwide cohort study (COSYCONET) [1], the influence of the reduced smoking rate on treatment costs was determined for the scenario of a reduction in the smoking rate of 26% in this patient group by 10 percentage points to 16 %. The assumption was made that with a reduced smoking rate, lower stages (I/II) will be more strongly represented, while higher and more cost- intensive stages (III/IV) will be proportionally reduced. The intervention to achieve tobacco abstinence was calculated for the rough model calculations with the typical costs of a guideline-compliant treatment by a behavioral therapy group cessation program and the parallel use of medication support [2, 3]. The result showed a potential reduction of case costs by 10.5%, not including reduction in costs associated with treatment of comorbidities.

Actions (login required)

View Item View Item